$8.12 +0.03 (%) Pozen Inc - NASDAQ

Sep. 17, 2014 | 04:00 PM

Partner Headlines

  1. UPDATE: Ascendiant Capital Markets Upgrades Pozen Following Q2 Results

    Benzinga | Aug. 8, 2014 | 08:16AM EST
  2. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga | Jul. 28, 2014 | 16:36PM EST
  3. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On Downbeat Results

    Benzinga | Jul. 16, 2014 | 15:57PM EST
  4. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga | Jul. 16, 2014 | 13:36PM EST
  5. Morning Market Losers

    Benzinga | Jul. 16, 2014 | 09:54AM EST
  6. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga | May. 14, 2014 | 12:36PM EST
  7. POZEN Receives CRL From FDA

    Benzinga | Apr. 28, 2014 | 16:45PM EST
  8. Morning Market Losers

    Benzinga | Apr. 28, 2014 | 09:51AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 28, 2014 | 08:09AM EST
  10. Pozen Submits Final Study Report for PA8140/PA32540 Phase 1 Study on Schedule

    Benzinga | Apr. 2, 2014 | 07:32AM EST
  11. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

    Benzinga | Mar. 17, 2014 | 04:42AM EST
  12. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD | Mar. 12, 2014 | 08:02AM EST
  13. Morning Market Losers

    Benzinga | Dec. 31, 2013 | 10:21AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 31, 2013 | 08:15AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Dec. 30, 2013 | 09:38AM EST
  16. POZEN New PA8140/PA32540 PDUFA Date is April 25, 2014

    Benzinga | Dec. 23, 2013 | 07:05AM EST
  17. POZEN Announces December 31, 2013 as Ex-Dividend Date for Previously Announced Special Cash Distribution

    Benzinga | Dec. 5, 2013 | 16:24PM EST
  18. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 22, 2013 | 08:21AM EST
  19. POZEN Announces Special Cash Distribution of $1.75/Share

    Benzinga | Nov. 21, 2013 | 16:07PM EST
  20. Horizon to Acquire US Rights for VIMOVO from Pozen

    Benzinga | Nov. 19, 2013 | 06:18AM EST
  21. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 5, 2013 | 08:10AM EST
  22. Stocks To Watch For September 5, 2013

    Benzinga | Sep. 5, 2013 | 04:20AM EST
  23. SANOFI

    IBD | Sep. 4, 2013 | 18:37PM EST
  24. Sanofi, Pozen Announce Exclusive License Deal for Commercialization of PA8140/PA32540 Tablets in US

    Benzinga | Sep. 4, 2013 | 16:05PM EST
  25. Pozen Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 9, 2012 | 07:04AM EST
  26. UPDATE: Ascendiant Capital Markets Initiates POZEN at Buy; Future Royalties Attractive

    Benzinga | Oct. 9, 2012 | 06:25AM EST
  27. POZEN Announces PA32540 Provides Superior Antiplatlet Effects over a Standard of Care Regimen in a Phase 1 Study ("Co-Rx")

    Benzinga | Aug. 29, 2012 | 01:32AM EST
  28. POZEN Provides Positive Update on Its PA Program and Results of Its Type A Meeting with the FDA

    Benzinga | Aug. 23, 2012 | 10:15AM EST
  29. POZEN Receives Patent on PA Products for Treatment of Cardiovascular Disease and Osteoarthritis

    Benzinga | Jun. 26, 2012 | 01:30AM EST
  30. Celgene, Bed Bath & Beyond Among Stocks Gapping Down Thursday

    FoxBusiness | Jun. 21, 2012 | 04:31AM EST
  31. Morning Market Losers

    Benzinga | Jun. 21, 2012 | 03:49AM EST
  32. POZEN Says FDA Does Not Agree That BioEquivalence Was Demonstrated

    Benzinga | Jun. 20, 2012 | 10:02AM EST
  33. POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 Migraine Treatment in 29 European Countries

    Benzinga | May. 8, 2012 | 01:37AM EST
Trading Center